Samir Patel
Fortune : 63 473 $ au 31/05/2025
Fortune : 63 473 $ au 31/05/2025
Dr. Samir R.
Patel, MD, is a President & Secretary at Peak Bio, Inc., a Chief Executive Officer at Digital Therapeutics LLC, a President, Secretary & Director at Pegasus Merger Sub, Inc., a Principal at Pranabio Investments LLC and a Principal at SPEC Pharma LLC.
He is on the Board of Directors at Akari Therapeutics Plc and Pegasus Merger Sub, Inc. Dr. Patel was previously employed as an Independent Director by CytoDyn, Inc., an Independent Director by Rezolute, Inc., and a Medical Affairs by Centocor, Inc. He received his undergraduate degree from the University of Cincinnati (Ohio) and a doctorate degree from the University of Toledo Medical Center.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AKARI THERAPEUTICS PLC 11,93 % | 01/06/2026 | 6 347 346 000 ( 11,93 % ) | 63 473 $ | 31/05/2025 |
| Sociétés | Poste | Début |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Directeur/Membre du Conseil | 29/11/2023 |
| PEAK BIO, INC. | President | 14/11/2024 |
SPEC Pharma LLC
SPEC Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which specializes in injectable therapies | Fondateur | - |
Digital Therapeutics LLC
Digital Therapeutics LLC Packaged SoftwareTechnology Services Develops application for personalized and gamified cognitive behavioral therapy to smokers trying to quit | Directeur Général | 01/08/2011 |
Pranabio Investments LLC
Pranabio Investments LLC Financial ConglomeratesFinance Provides investment services | Fondateur | - |
Pegasus Merger Sub, Inc. | President | - |
| Sociétés | Poste | Fin |
|---|---|---|
| CYTODYN INC. | Directeur/Membre du Conseil | 28/10/2021 |
| REZOLUTE, INC. | Directeur/Membre du Conseil | 10/02/2019 |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
CytoDyn, Inc.
CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
University of Cincinnati (Ohio)
University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toledo Medical Center
University of Toledo Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rezolute, Inc.
Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
Akari Therapeutics Plc
Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Pranabio Investments LLC
Pranabio Investments LLC Financial ConglomeratesFinance Provides investment services | Finance |
SPEC Pharma LLC
SPEC Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which specializes in injectable therapies | Health Technology |
Digital Therapeutics LLC
Digital Therapeutics LLC Packaged SoftwareTechnology Services Develops application for personalized and gamified cognitive behavioral therapy to smokers trying to quit | Technology Services |
Peak Bio, Inc.
Peak Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics to treat oncology and inflammatory diseases | Health Technology |
Pegasus Merger Sub, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national